DGIdb - PIRFENIDONE Drug Record

PIRFENIDONE chembl:CHEMBL1256391 ApprovedAntineoplasticImmunotherapy

Alternate Names:

AMR-69

PIRFENIDONE

ESBRIET

ESBRIET®

AMR 69

chembl:CHEMBL1256391

pubchem.compound:40632

rxcui:1592254

chemidplus:53179-13-8

drugbank:04951

Drug Info:

FDA Approval not approved

Drug Class small molecule

Drug Indications for treatment of fibrotic conditions

(1 More Sources)

Publications:

Lindor et al., 2003, Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone., Am. J. Gastroenterol.

PIRFENIDONE TGFB1

Interaction Score: 0.72

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
12907346

Sources:
NCI TTD
PIRFENIDONE MAPK13

Interaction Score: 0.38

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
PIRFENIDONE MAPK11

Interaction Score: 0.38

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
PIRFENIDONE MAPK12

Interaction Score: 0.34

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
PIRFENIDONE MAPK14

Interaction Score: 0.12

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
PIRFENIDONE HSD17B10

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
PIRFENIDONE CYP1A2

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC

TdgClinicalTrial: PIRFENIDONE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications for treatment of fibrotic conditions

Drug Class small molecule

FDA Approval not approved

Publications:
NCI: PIRFENIDONE
- Version: 14-September-2017
Alternate Names:

C2635 NCI drug code

Drug Info:

Publications:

Lindor et al., 2003, Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone., Am. J. Gastroenterol.
TTD: Pirfenidone
- Version: 2020.06.01
Alternate Names:

D02WCI TTD Drug ID

Drug Info:

Publications:
DTC: PIRFENIDONE
- Version: 02-September-2020
Alternate Names:

CHEMBL1256391 ChEMBL Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL1256391
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

FDA Approval	not approved
Drug Class	small molecule
Drug Indications	for treatment of fibrotic conditions

Trial Name	pirfenidone,Esbriet , Deskar, Pirespa
Novel drug target	Novel Target

AMR-69
PIRFENIDONE
ESBRIET
ESBRIET®
AMR 69
chembl:CHEMBL1256391
pubchem.compound:40632
rxcui:1592254
chemidplus:53179-13-8
drugbank:04951

PIRFENIDONE Drug Record

PIRFENIDONE chembl:CHEMBL1256391 ApprovedAntineoplasticImmunotherapy

Alternate Names:

Drug Info:

Publications:

PIRFENIDONE TGFB1

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 12907346

Sources: NCI TTD

PIRFENIDONE MAPK13

Interaction Types & Directionality: n/a

Interaction Info: Trial Name pirfenidone,Esbriet , Deskar, Pirespa Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

PIRFENIDONE MAPK11

Interaction Types & Directionality: n/a

Interaction Info: Trial Name pirfenidone,Esbriet , Deskar, Pirespa Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

PIRFENIDONE MAPK12

Interaction Types & Directionality: n/a

Interaction Info: Trial Name pirfenidone,Esbriet , Deskar, Pirespa Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

PIRFENIDONE MAPK14

Interaction Types & Directionality: n/a

Interaction Info: Trial Name pirfenidone,Esbriet , Deskar, Pirespa Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

PIRFENIDONE HSD17B10

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

PIRFENIDONE CYP1A2

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

TdgClinicalTrial: PIRFENIDONE

Alternate Names:

Drug Info: Drug Indications for treatment of fibrotic conditions Drug Class small molecule FDA Approval not approved

Publications:

NCI: PIRFENIDONE

Alternate Names: C2635 NCI drug code

Drug Info:

Publications: Lindor et al., 2003, Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone., Am. J. Gastroenterol.

TTD: Pirfenidone

Alternate Names: D02WCI TTD Drug ID

Drug Info:

Publications:

DTC: PIRFENIDONE

Alternate Names: CHEMBL1256391 ChEMBL Drug ID

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL1256391

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
12907346

Sources:
NCI TTD

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name pirfenidone,Esbriet , Deskar, Pirespa

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Drug Info:

Drug Indications for treatment of fibrotic conditions

Drug Class small molecule

FDA Approval not approved

Alternate Names:

C2635 NCI drug code

Publications:

Lindor et al., 2003, Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone., Am. J. Gastroenterol.

Alternate Names:

D02WCI TTD Drug ID

Alternate Names:

CHEMBL1256391 ChEMBL Drug ID